Researchers Identified New RNA Backbone Modification
The finding marks the first known chemical modification of the RNA phosphate backbone, potentially enabling new therapeutic production tools.
Updated on Oct. 2, 2026 in Life Sciences
Live Poll
Do breakthroughs in RNA modification technology make you more confident in future medical treatments?
An international research team has identified the first naturally occurring modification of the RNA phosphate backbone. While science has previously recognized over 150 RNA chemical modifications, all were restricted to nucleobases or ribose sugars until this research.
Why it matters
The discovery challenges the long-standing scientific assumption that the RNA phosphate backbone is chemically invariant, providing a potential mechanism for how living organisms regulate complex RNA molecules. This finding now suggests that specific enzymes could be leveraged to engineer stable nucleic acid therapeutics.
Researchers identified that Esti enzymes introduce phosphorothioate modifications stereospecifically into the RNA backbone. This result expands the known chemical landscape of RNA beyond the 150 existing modifications identified in previous research.
The players
Esti enzymes
Biological catalysts identified for their ability to introduce phosphorothioate modifications into the RNA backbone.
The details
The team identified the modification by investigating archaeal evolution to isolate the enzymatic mechanism involved. Esti enzymes function as the biological tools that catalyze these stereospecific changes, which are precise structural alterations where atoms are arranged in a specific spatial orientation. By successfully mapping this modification to the phosphate backbone—the chain of sugar and phosphate groups that form the structure of an RNA molecule—the researchers provide a new method for stabilizing synthetic RNA.
Timeline
October 2, 2026: Research findings were published.
The Tech Race
This discovery updates the foundational understanding of nucleic acid chemistry by documenting the first known phosphate backbone modification. It situates the study within the broader effort to move beyond the 150 known modifications to engineer more stable therapeutic RNA structures.
This research provides a new architectural tool for developers working on stable nucleic acid therapeutics. While the technology is currently in the research stage, it offers a future pathway for creating more durable medical treatments by leveraging engineered enzymatic pathways.
The takeaway
The identification of this backbone modification shifts the focus of synthetic biology toward the phosphate chain as a target for therapeutic engineering. Researchers and drug developers should monitor subsequent studies to see if these Esti enzymes can be reliably programmed for commercial pharmaceutical synthesis.
Further reading
Learn more about the latest developments in molecular engineering at /science/life-sciences/.
Source note: This article includes information reported by Analytik.
Live Poll
Do breakthroughs in RNA modification technology make you more confident in future medical treatments?
